Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost/benefit aspects on thromboprophylaxis

D Bergqvist1, T Mätzsch

  • 1Department of Surgery, Lund University, Malmö General Hospital, Sweden.

Haemostasis
|March 1, 1993
PubMed
Summary

Low molecular weight heparin (LMWH) is more cost-effective for thromboprophylaxis than standard heparin. This finding supports LMWH as a preferred economic choice for preventing blood clots in most clinical scenarios.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cranial nerve injuries after carotid artery surgery. A prospective study of 663 operations.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1995
Same author

[Arterial surgery of the extremities without angiography. A simpler preoperative survey with color doppler].

Lakartidningen·1995
Same author

The haemorrhagic effect of low molecular weight heparins, dermatan sulphate and hirudin.

Haemostasis·1995
Same author

Intraplaque haemorrhage at carotid artery surgery--a predictor of cardiovascular mortality.

Journal of internal medicine·1995
Same author

[Vascular surgeons make comparison with the USA. Low level of Swedish control over implants].

Lakartidningen·1995
Same author

Reduction of requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS).

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·1995

Area of Science:

  • Pharmacoeconomics
  • Thrombosis Prevention
  • Medical Cost-Effectiveness

Background:

  • Thromboprophylaxis is established as more cost-effective than no treatment or selective approaches.
  • Limited cost-effectiveness data exists specifically for low molecular weight heparins (LMWH).

Purpose of the Study:

  • To evaluate the cost-effectiveness of low molecular weight heparin compared to standard low-dose heparin for thromboprophylaxis.

Main Methods:

  • Comparative cost-effectiveness analysis.
  • Review of existing literature and clinical data.

Main Results:

  • Low molecular weight heparin demonstrated superior cost-effectiveness over standard low-dose heparin in the majority of evaluated prophylactic situations.
  • This suggests a favorable economic profile for LMWH in preventing thromboembolic events.

Conclusions:

  • Low molecular weight heparin represents a more cost-effective option for thromboprophylaxis compared to standard low-dose heparin.
  • The findings support the wider adoption of LMWH for economic and clinical benefits in clot prevention.

Related Experiment Videos